losartan has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| deBlois, D; Der Sarkissian, S; Hamet, P; Marchand, EL | 1 |
| Li, XP; Uhal, BD; Yian, KR; Zhuang, JJ | 1 |
3 other study(ies) available for losartan and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antihypertensive Agents; Aorta; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; Body Weight; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Count; DNA Fragmentation; Hypertension; Hypertrophy; In Situ Nick-End Labeling; Losartan; Male; Muscle, Smooth, Vascular; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred SHR; Remission Induction; Time Factors | 2003 |
Apoptosis-dependent acute pulmonary injury after intratracheal instillation of angiotensin II.
Topics: Amino Acid Chloromethyl Ketones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Epithelial Cells; Losartan; Lung Injury; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1 | 2008 |